Safety and Efficacy of Saxagliptin Plus Insulin With or Without Metformin
Public ClinicalTrials.gov record NCT00757588. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Phase 3 Trial to Evaluate the Efficacy and Safety of Saxagliptin Added to Insulin Monotherapy or to Insulin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Insulin Alone or on Insulin in Combination With Metformin
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to compare the effects of saxagliptin with those of placebo as add-on therapy to insulin and insulin with metformin in improving glycemic control at 24 and 52 weeks.
Study identification
- NCT ID
- NCT00757588
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 455 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 78 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2008
- Primary completion
- Mar 31, 2010
- Completion
- Mar 31, 2010
- Last update posted
- May 31, 2015
2008 – 2010
United States locations
- U.S. sites
- 16
- U.S. states
- 9
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Research Advantage, Inc | Tempe | Arizona | 85282 | — |
| Valley Research | Fresno | California | 93720 | — |
| Torrance-Lomita Medical Center | Lomita | California | 90717 | — |
| Diabetes Medical Center Of California | Northridge | California | 91325 | — |
| Ritchken & First M.D.'S | San Diego | California | 92117 | — |
| Encompass Clinical Research | Spring Valley | California | 91978 | — |
| Central Florida Clinical Trials, Inc. | Altamonte Springs | Florida | 32701 | — |
| Family Care Associates Of Nw Florida | Chipley | Florida | 32428 | — |
| Panhandle Family Care Assoc. & Coastal Palms Res. Grp Inc. | Marianna | Florida | 32446 | — |
| Endocrine Research Solutions, Inc. | Roswell | Georgia | 30076 | — |
| Danny W. Jackson P.A. | Rolling Fork | Mississippi | 39159 | — |
| Southgate Medical Group | West Seneca | New York | 14224 | — |
| Southeastern Research Associates, Inc. | Taylors | South Carolina | 29687 | — |
| Texas Center For Drug Development | Houston | Texas | 77081 | — |
| Dgd Research, Inc. | San Antonio | Texas | 78229 | — |
| Aurora Advanced Healthcare | Milwaukee | Wisconsin | 53209 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 64 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00757588, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 31, 2015 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00757588 live on ClinicalTrials.gov.